Patents Assigned to Enable Biosciences Inc.
  • Patent number: 12553893
    Abstract: Some embodiments of the systems and methods provided herein relate to an assay. Some such embodiments include multiplex affinity probes and an antigen probe. multiplex affinity probes and an antigen probe Some embodiments include contacting a biological sample with the probes, wherein target binding agents such as antibodies in the biological sample compete away the multiplex affinity probes from binding to the antigen probe. Some such embodiments include detecting a decrease in binding of the multiplex affinity probes to the antigen probe, thereby indicating the presence or an amount of the target binding agents in the biological sample.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: February 17, 2026
    Assignee: Enable Biosciences Inc.
    Inventors: Cheng-Ting Tsai, Peter Robinson
  • Patent number: 12428675
    Abstract: Methods and reagents for blocking non-specific interactions with nucleic acids are disclosed. In particular, the invention relates to multi-valent blockers comprising multiple negatively charged polymers or materials attached to a common scaffold and their use in blocking non-specific interactions with nucleic acids.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: September 30, 2025
    Assignee: Enable Biosciences Inc.
    Inventors: Cheng-Ting Tsai, Peter Robinson
  • Patent number: 11053538
    Abstract: Methods and reagents for blocking non-specific interactions with nucleic acids are disclosed. In particular, the invention relates to multi-valent blockers comprising multiple negatively charged polymers or materials attached to a common scaffold and their use in blocking non-specific interactions with nucleic acids.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: July 6, 2021
    Assignee: Enable Biosciences Inc.
    Inventors: Cheng-Ting Tsai, Peter Robinson